| Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli … G Bacci, S Ferrari, F Bertoni, P Ruggieri, P Picci, A Longhi, R Casadei, ... Journal of clinical oncology 18 (24), 4016-4027, 2000 | 533 | 2000 |
| Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli G Bacci, S Ferrari, F Bertoni, S Rimondini, A Longhi, P Bacchini, C Forni, ... Journal of Clinical Oncology 18 (1), 4-4, 2000 | 358 | 2000 |
| Osteosarcoma of the limb: amputation or limb salvage in patients treated by neoadjuvant chemotherapy G Bacci, S Ferrari, S Lari, M Mercuri, D Donati, A Longhi, C Forni, ... The Journal of Bone & Joint Surgery British Volume 84 (1), 88-92, 2002 | 281 | 2002 |
| Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremity: histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor G Bacci, F Bertoni, A Longhi, S Ferrari, C Forni, R Biagini, P Bacchini, ... Cancer 97 (12), 3068-3075, 2003 | 269 | 2003 |
| Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin … G Bacci, A Briccoli, M Rocca, S Ferrari, D Donati, A Longhi, F Bertoni, ... Annals of Oncology 14 (7), 1126-1134, 2003 | 243 | 2003 |
| High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic … G Bacci, M Rocca, MC Salone, A Balladelli, S Ferrari, E Palmerini, C Forni, ... Journal of surgical oncology 98 (6), 415-420, 2008 | 223 | 2008 |
| Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992 G Bacci, C Forni, A Longhi, S Ferrari, D Donati, M De Paolis, E Barbieri, ... European Journal of Cancer 40 (1), 73-83, 2004 | 207 | 2004 |
| Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol G Bacci, A Briccoli, S Ferrari, A Longhi, M Mercuri, R Capanna, D Donati, ... European Journal of Cancer 37 (16), 2030-2039, 2001 | 206 | 2001 |
| Predictive factors for local recurrence in osteosarcoma 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy G Bacci, S Ferrari, M Mercuri, F Bertoni, P Picci, M Manfrini, A Gasbarrini, ... Acta Orthopaedica Scandinavica 69 (3), 230-236, 1998 | 188 | 1998 |
| Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: a 27‐year experience in a single institution G Bacci, C Forni, A Longhi, S Ferrari, M Mercuri, F Bertoni, M Serra, ... Journal of surgical oncology 96 (2), 118-123, 2007 | 183 | 2007 |
| Osteogenic sarcoma of the extremity with detectable lung metastases at presentation: Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of … G Bacci, M Mercuri, A Briccoli, S Ferrari, F Bertoni, D Donati, C Monti, ... Cancer 79 (2), 245-254, 1997 | 147 | 1997 |
| One-year mortality after hip fracture surgery and prognostic factors: a prospective cohort study M Morri, E Ambrosi, P Chiari, A Orlandi Magli, D Gazineo, F D’Alessandro, ... Scientific reports 9 (1), 18718, 2019 | 146 | 2019 |
| Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation Local and systemic control by amputation or limb salvage after preoperative chemotherapy G Bacci, S Ferrari, A Longhi, D Donati, M Manfrini, S Giacomini, A Briccoli, ... Acta Orthopaedica Scandinavica 74 (4), 449-454, 2003 | 143 | 2003 |
| Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy G Bacci, S Ferrari, A Longhi, S Perin, C Forni, N Fabbri, N Salduca, ... European Journal of Cancer 37 (1), 32-38, 2001 | 140 | 2001 |
| Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997 G Bacci, S Ferrari, A Longhi, D Donati, M De Paolis, C Forni, M Versari, ... Annals of Oncology 14 (11), 1654-1659, 2003 | 137 | 2003 |
| High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an … G Bacci, S Ferrari, A Longhi, P Picci, M Mercuri, TA Alvegard, G Saeter, ... Journal of chemotherapy 14 (2), 198-206, 2002 | 103 | 2002 |
| Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary … G Bacci, C Forni, S Ferrari, A Longhi, F Bertoni, M Mercuri, D Donati, ... Journal of pediatric hematology/oncology 25 (11), 845-853, 2003 | 100 | 2003 |
| Neoadjuvant chemotherapy for Ewing's sarcoma of bone: No benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin … G Bacci, P Picci, S Ferrari, M Mercuri, AB Prever, P Rosito, E Barbieri, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 98 | 1998 |
| Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute G Bacci, A Longhi, S Ferrari, S Lari, M Manfrini, D Donati, C Forni, ... Oncology reports 9 (1), 171-175, 2002 | 91 | 2002 |
| Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide. G Bacci, A Briccoli, S Ferrari, G Saeter, D Donati, A Longhi, M Manfrini, ... Oncology reports 7 (2), 339-385, 2000 | 91 | 2000 |
